Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

University Hospitals Leuven

Research site

Belgium Herestraat 49, 3000 Leuven, Belgium, Leuven, Belgium

  • 5 trials recruiting
  • Acute myocardial infarction · Atrial fibrillation · Cardiogenic shock
  • Adults and children

About Specializations

University Hospitals Leuven in Leuven, Belgium specialises in clinical trials of conditions such as Acute myocardial infarction, Atrial fibrillation, Cardiogenic shock, Cerebrovascular accident, and other specialisations. This site conducts important research.

Main research areas of the site

Oncology

The medical center is at the forefront of oncology research, particularly focusing on high-risk neuroblastoma. This complex and aggressive cancer primarily affects children, and the center is dedicated to improving treatment outcomes through innovative therapeutic strategies.

  • High-Risk Neuroblastoma Treatment
  • Chemoimmunotherapy Advancements
  • Radiotherapy Techniques

By conducting a randomized, international, and multicentric phase 3 study, the center evaluates and compares two treatment strategies across three therapeutic phases: induction, high-dose chemotherapy, and radiotherapy. This research introduces chemoimmunotherapy for patients with insufficient metastatic response after induction chemotherapy, aiming to enhance survival rates and quality of life.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Herestraat 49, 3000 Leuven, BelgiumLeuvenBelgium
Open in maps ↗
Recruiting now
5 trials
Conditions studied
8

More sites in LeuvenBelgium

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

5 clinical trials

Acute myocardial infarction+1

Recruiting

Bisoprolol in Patients After Myocardial Infarction with Preserved Ejection Fraction During Cardiac Rehabilitation

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Bisoprolol
  • Sponsor:UZ Leuven

Neuroblastoma

Recruiting

Study on High-Risk Neuroblastoma Treatment with Busulfan, Melphalan, and Drug Combination for Patients with Insufficient Metastatic Response

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:0–17 years · 18–64 years
  • Substances:Busulfan
  • Sponsor:Institut Gustave Roussy

Atrial fibrillation+2

Recruiting

Study on Apixaban and Edoxaban for Preventing Stroke in Patients with Recent Perioperative Atrial Fibrillation After Noncardiac Surgery

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Hamilton Health Sciences Corporation

Acute myocardial infarction+1

Recruiting

Study of Lower Blood Pressure Targets Using Noradrenaline in Patients with Heart Attack-Related Cardiogenic Shock

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Noradrenaline Tartrate
  • Sponsor:Amsterdam UMC Stichting

Myocarditis

Recruiting

Study on the Safety and Effectiveness of Methylprednisolone Sodium Succinate and Sodium Chloride for Patients with Severe Cardiac Inflammation

Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:ASST Grande Ospedale Metropolitano Niguarda
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.